A detailed history of Met Life Investment Management, LLC transactions in Geron Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 323,659 shares of GERN stock, worth $1.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
323,659
Previous 332,762 2.74%
Holding current value
$1.18 Million
Previous $1.41 Million 4.18%
% of portfolio
0.01%
Previous 0.01%

Shares

70 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.17 - $4.99 $37,959 - $45,423
-9,103 Reduced 2.74%
323,659 $1.47 Million
Q2 2024

Aug 13, 2024

BUY
$3.1 - $5.09 $189,682 - $311,446
61,188 Added 22.53%
332,762 $1.41 Million
Q1 2024

May 14, 2024

BUY
$1.75 - $3.44 $475,254 - $934,214
271,574 New
271,574 $896,000
Q3 2023

May 09, 2024

BUY
$2.11 - $3.28 $79,122 - $122,996
37,499 Added 16.65%
262,662 $556,000
Q2 2023

Apr 29, 2024

BUY
$1.97 - $3.69 $517,444 - $969,222
262,662 New
262,662 $843,000
Q2 2023

Aug 10, 2023

BUY
$1.97 - $3.69 $73,873 - $138,371
37,499 Added 16.65%
262,662 $843,000
Q1 2023

May 09, 2024

BUY
$2.14 - $3.4 $481,848 - $765,554
225,163 New
225,163 $489 Million
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $107,903 - $171,434
50,422 Added 28.86%
225,163 $488,000
Q4 2022

May 10, 2024

SELL
$2.03 - $2.42 $34,254 - $40,835
-16,874 Reduced 8.81%
174,741 $422,000
Q4 2022

Jun 14, 2023

SELL
$2.03 - $2.42 $102,356 - $122,021
-50,422 Reduced 22.39%
174,741 $422,000
Q4 2022

Mar 22, 2023

SELL
$2.03 - $2.42 $34,254 - $40,835
-16,874 Reduced 8.81%
174,741 $422,000
Q4 2022

Feb 15, 2023

SELL
$2.03 - $2.42 $34,254 - $40,835
-16,874 Reduced 8.81%
174,741 $422,000
Q3 2022

May 10, 2024

BUY
$1.67 - $2.94 $91,642 - $161,335
54,876 Added 40.13%
191,615 $448,000
Q3 2022

Jun 14, 2023

SELL
$1.67 - $2.94 $56,025 - $98,631
-33,548 Reduced 14.9%
191,615 $448,000
Q3 2022

Mar 22, 2023

BUY
$1.67 - $2.94 $91,642 - $161,335
54,876 Added 40.13%
191,615 $448,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $91,642 - $161,335
54,876 Added 40.13%
191,615 $448,000
Q2 2022

May 10, 2024

SELL
$1.19 - $1.65 $8,459 - $11,729
-7,109 Reduced 4.94%
136,739 $211,000
Q2 2022

Jun 20, 2023

SELL
$1.19 - $1.65 $105,224 - $145,899
-88,424 Reduced 39.27%
136,739 $211,000
Q2 2022

Mar 22, 2023

SELL
$1.19 - $1.65 $8,459 - $11,729
-7,109 Reduced 4.94%
136,739 $211,000
Q2 2022

Aug 11, 2022

SELL
$1.19 - $1.65 $8,459 - $11,729
-7,109 Reduced 4.94%
136,739 $212,000
Q1 2022

May 10, 2024

BUY
$0.99 - $1.6 $142,409 - $230,156
143,848 New
143,848 $195,000
Q1 2022

Jun 20, 2023

SELL
$0.99 - $1.6 $80,501 - $130,104
-81,315 Reduced 36.11%
143,848 $195,000
Q1 2022

Mar 22, 2023

BUY
$0.99 - $1.6 $28,402 - $45,902
28,689 Added 24.91%
143,848 $195,000
Q1 2022

May 12, 2022

BUY
$0.99 - $1.6 $28,402 - $45,902
28,689 Added 24.91%
143,848 $196,000
Q4 2021

May 17, 2024

BUY
$1.22 - $1.72 $63,908 - $90,100
52,384 Added 83.45%
115,159 $140,000
Q4 2021

Jun 21, 2023

SELL
$1.22 - $1.72 $134,204 - $189,206
-110,004 Reduced 48.86%
115,159 $140,000
Q4 2021

Mar 22, 2023

BUY
$1.22 - $1.72 $63,908 - $90,100
52,384 Added 83.45%
115,159 $140,000
Q4 2021

Feb 15, 2022

BUY
$1.22 - $1.72 $63,908 - $90,100
52,384 Added 83.45%
115,159 $140,000
Q3 2021

May 17, 2024

SELL
$1.2 - $1.5 $69,393 - $86,742
-57,828 Reduced 47.95%
62,775 $86,000
Q3 2021

Jun 21, 2023

SELL
$1.2 - $1.5 $194,865 - $243,582
-162,388 Reduced 72.12%
62,775 $86,000
Q3 2021

Mar 22, 2023

SELL
$1.2 - $1.5 $69,393 - $86,742
-57,828 Reduced 47.95%
62,775 $86,000
Q3 2021

Nov 15, 2021

SELL
$1.2 - $1.5 $69,393 - $86,742
-57,828 Reduced 47.95%
62,775 $86,000
Q2 2021

May 17, 2024

BUY
$1.25 - $1.83 $84,795 - $124,139
67,836 Added 128.56%
120,603 $170,000
Q2 2021

Jun 21, 2023

SELL
$1.25 - $1.83 $130,700 - $191,344
-104,560 Reduced 46.44%
120,603 $170,000
Q2 2021

Mar 22, 2023

BUY
$1.25 - $1.83 $84,795 - $124,139
67,836 Added 128.56%
120,603 $170,000
Q2 2021

Aug 16, 2021

BUY
$1.25 - $1.83 $84,795 - $124,139
67,836 Added 128.56%
120,603 $170,000
Q1 2021

May 17, 2024

SELL
$1.52 - $2.1 $332,586 - $459,494
-218,807 Reduced 80.57%
52,767 $83,000
Q1 2021

Jun 26, 2023

SELL
$1.52 - $2.1 $262,041 - $362,031
-172,396 Reduced 76.56%
52,767 $83.4 Million
Q1 2021

Mar 22, 2023

SELL
$1.52 - $2.1 $114,095 - $157,632
-75,063 Reduced 58.72%
52,767 $83,000
Q1 2021

May 14, 2021

SELL
$1.52 - $2.1 $114,095 - $157,632
-75,063 Reduced 58.72%
52,767 $83,000
Q4 2020

May 24, 2024

SELL
$1.55 - $2.05 $3,681 - $4,868
-2,375 Reduced 1.82%
127,830 $203,000
Q4 2020

Jun 22, 2023

SELL
$1.55 - $2.05 $150,866 - $199,532
-97,333 Reduced 43.23%
127,830 $203,000
Q4 2020

Mar 22, 2023

SELL
$1.55 - $2.05 $3,681 - $4,868
-2,375 Reduced 1.82%
127,830 $203,000
Q4 2020

Feb 16, 2021

SELL
$1.55 - $2.05 $3,681 - $4,868
-2,375 Reduced 1.82%
127,830 $203,000
Q3 2020

May 24, 2024

BUY
$1.59 - $2.19 $59,445 - $81,877
37,387 Added 40.28%
130,205 $227 Million
Q3 2020

Jun 26, 2023

SELL
$1.59 - $2.19 $150,983 - $207,958
-94,958 Reduced 42.17%
130,205 $226,000
Q3 2020

Mar 22, 2023

BUY
$1.59 - $2.19 $59,445 - $81,877
37,387 Added 40.28%
130,205 $226,000
Q3 2020

Nov 13, 2020

BUY
$1.59 - $2.19 $59,445 - $81,877
37,387 Added 40.28%
130,205 $227,000
Q2 2020

May 24, 2024

SELL
$1.05 - $2.18 $187,693 - $389,688
-178,756 Reduced 65.82%
92,818 $202 Million
Q2 2020

Jun 26, 2023

SELL
$1.05 - $2.18 $138,962 - $288,512
-132,345 Reduced 58.78%
92,818 $202,000
Q1 2020

Jul 12, 2023

SELL
$0.89 - $1.49 $117,787 - $197,194
-132,345 Reduced 58.78%
92,818 $110,000
Q1 2020

Mar 22, 2023

BUY
$0.89 - $1.49 $61,837 - $103,525
69,480 Added 297.71%
92,818 $110,000
Q1 2020

May 15, 2020

BUY
$0.89 - $1.49 $61,837 - $103,525
69,480 Added 297.71%
92,818 $110,000
Q4 2019

Jul 12, 2023

SELL
$1.27 - $1.54 $256,317 - $310,810
-201,825 Reduced 89.64%
23,338 $31,000
Q4 2019

Mar 22, 2023

SELL
$1.27 - $1.54 $87,538 - $106,149
-68,928 Reduced 74.71%
23,338 $31,000
Q4 2019

Feb 14, 2020

SELL
$1.27 - $1.54 $87,538 - $106,149
-68,928 Reduced 74.71%
23,338 $32,000
Q3 2019

Jul 12, 2023

SELL
$1.15 - $1.59 $152,831 - $211,306
-132,897 Reduced 59.02%
92,266 $122,000
Q3 2019

Mar 22, 2023

BUY
$1.15 - $1.59 $2,327 - $3,218
2,024 Added 2.24%
92,266 $122,000
Q3 2019

Nov 14, 2019

BUY
$1.15 - $1.59 $2,327 - $3,218
2,024 Added 2.24%
92,266 $123,000
Q2 2019

Jul 12, 2023

SELL
$1.37 - $2.02 $184,841 - $272,540
-134,921 Reduced 59.92%
90,242 $127,000
Q1 2019

Jul 13, 2023

SELL
$1.01 - $1.83 $136,270 - $246,905
-134,921 Reduced 59.92%
90,242 $149,000
Q1 2019

Mar 22, 2023

SELL
$1.01 - $1.83 $27,195 - $49,274
-26,926 Reduced 22.98%
90,242 $149,000
Q1 2019

May 15, 2019

BUY
$1.01 - $1.83 $91,144 - $165,142
90,242 New
90,242 $150,000
Q4 2018

Feb 14, 2019

SELL
$0.98 - $1.85 $114,824 - $216,760
-117,168 Closed
0 $0
Q3 2018

Jul 13, 2023

SELL
$1.76 - $6.38 $259,659 - $941,266
-147,534 Reduced 65.52%
77,629 $136,000
Q3 2018

Mar 22, 2023

SELL
$1.76 - $6.38 $101,328 - $367,315
-57,573 Reduced 32.95%
117,168 $206,000
Q3 2018

Nov 14, 2018

BUY
$1.76 - $6.38 $68,807 - $249,426
39,095 Added 50.07%
117,168 $206,000
Q2 2018

Aug 15, 2018

BUY
$3.29 - $4.82 $107,819 - $157,961
32,772 Added 72.34%
78,073 $268,000
Q1 2018

May 15, 2018

SELL
$1.81 - $5.98 $54,819 - $181,116
-30,287 Reduced 40.07%
45,301 $193,000
Q4 2017

Feb 15, 2018

BUY
$1.8 - $2.32 $136,058 - $175,364
75,588
75,588 $136,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.38B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.